Biotech Values

[DewDiligence]

MNTA Major Shareholders

[Updated for 3Q11 13F-HR filings.]


The table below shows all shareholders who filed their MNTA holdings
on SEC Form 13-G in Feb 2011 (or later); the holdings are updated quarterly
for filings on Form 13F-HR (except Novartis) and are accurate as of 9/30/11.
The percentages in the table are based on 53.3M diluted shares (#msg-65636329)
and do not concur with the percentages on Form 13-G, which use a different formula.

 
                            Shares    Stake 
 Novartis                  4,708,679   8.8% 
 T Rowe Price              3,509,347   6.6% 
 Discovery Capital Mgmt    2,725,911   5.1% 
 Palo Alto Investors       2,617,788   4.9% 
 Wellington                2,482,563   4.7% 
 Fidelity (FMR)            1,917,214   3.6% 
 BlackRock                 1,399,010   2.6% 
 Oppenheimer                 488,204   0.9%